Sarah H. Yi

1.0k citations

36 papers · 638 indexed · h-index 14

Infectious Diseases top 10%
Epidemiology
Surgery
Critical Care and Intensive Care Medicine top 5%
Emergency Medical Services top 5%

Co-authors: John A. Jernigan James Baggs L. Clifford McDonald Kelly M Hatfield Rani H. Singh Sujan Reddy Sophia V. Kazakova Sandra I. Berríos-Torres
Topics: Clostridium difficile and Clostridium perfringens research (8 papers)Antibiotic Use and Resistance (7 papers)Nosocomial Infections in ICU (7 papers)
Cited by: Applied Microbiology and Biotechnology Critical Care and Intensive Care Medicine Emergency Medical Services
Journals: SHILAP Revista de lepidopterologíaClinical Infectious Diseases The FASEB Journal
Partner nations: United States Uganda Australia

In The Last Decade

Sarah H. Yi

32 papers receiving 621 citations

Peers

Countries citing papers authored by Sarah H. Yi

Since Specialization

Citations

This map shows the geographic impact of Sarah H. Yi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sarah H. Yi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sarah H. Yi more than expected).

Fields of papers citing papers by Sarah H. Yi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sarah H. Yi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sarah H. Yi. The network helps show where Sarah H. Yi may publish in the future.

Co-authorship network of co-authors of Sarah H. Yi

This figure shows the co-authorship network connecting the top 25 collaborators of Sarah H. Yi. A scholar is included among the top collaborators of Sarah H. Yi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sarah H. Yi. Sarah H. Yi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Length of antibiotic therapy among adults hospitalized with uncomplicated community-acquired pneumonia, 2013–2020 2024 ·Infection Control and Hospital Epidemiology ·Natalie McCarthy,James Baggs,Hannah Wolford,Sophia V. Kazakova,Sarah Kabbani,(unknown),Melinda M. Neuhauser,(unknown),Sarah H. Yi,Kelly M Hatfield,Sujan Reddy,Lauri A. Hicks	2
2	Trends in facility-level rates of Clostridioides difficile infections in US hospitals, 2019–2020 2022 ·Infection Control and Hospital Epidemiology ·(unknown),James Baggs,Sophia V. Kazakova,Alice Guh,Sarah H. Yi,Natalie McCarthy,John A. Jernigan,Sujan Reddy	5
3	Associations of facility-level antibiotic use and hospital-onset Clostridioides difficile infection in US acute-care hospitals, 2012–2018 2021 ·Infection Control and Hospital Epidemiology ·Sophia V. Kazakova,James Baggs,Sarah H. Yi,Sujan Reddy,Kelly M Hatfield,Alice Guh,John A. Jernigan,L. Clifford McDonald	9
4	Reductions in inpatient fluoroquinolone use and postdischarge Clostridioides difficile infection (CDI) from a systemwide antimicrobial stewardship intervention 2021 ·SHILAP Revista de lepidopterología ·K. A. Jones,(unknown),(unknown),Benjamin Albrecht,(unknown),Jessica Howard‐Anderson,Sujit Suchindran,Ronald P. Trible,Jesse T. Jacob,Sarah H. Yi,(unknown),Scott K. Fridkin,(unknown),Zanthia Wiley	2
5	COVID-19 Vaccine Uptake Among Residents and Staff Members of Assisted Living and Residential Care Communities—Pharmacy Partnership for Long-Term Care Program, December 2020–April 2021 2021 ·Journal of the American Medical Directors Association ·Radhika Gharpure,Sarah H. Yi,Ruoran Li,Kara M. Jacobs Slifka,Ashley Tippins,(unknown),Angela Guo,Alyssa G. Kent,Katryna A. Gouin,(unknown),(unknown),Anita Patel,Matthew J. Stuckey,Ruth Link‐Gelles	10
6	Vascular Access and Risk of Bloodstream Infection Among Older Incident Hemodialysis Patients 2020 ·Kidney Medicine ·Sophia V. Kazakova,James Baggs,(unknown),Sarah H. Yi,John A. Jernigan,Duc B. Nguyen,Priti R. Patel	6
7	Characterization of COVID-19 in Assisted Living Facilities — 39 States, October 2020 2020 ·MMWR Morbidity and Mortality Weekly Report ·Sarah H. Yi,Isaac See,Alyssa G. Kent,(unknown),(unknown),Kerui Xu,Katryna A. Gouin,Shirley Zhang,Kara Jacobs Slifka,Ann Goding Sauer,Preeta K. Kutty,Joseph F. Perz,Nimalie D. Stone,Matthew J. Stuckey	29
8	Association Between Antibiotic Use and Hospital-onset Clostridioides difficile Infection in US Acute Care Hospitals, 2006–2012: An Ecologic Analysis 2019 ·Clinical Infectious Diseases ·Sophia V. Kazakova,James Baggs,L. Clifford McDonald,Sarah H. Yi,Kelly M Hatfield,Alice Guh,Sujan Reddy,John A. Jernigan	61
9	Reduction in Clostridium difficile infection rates following a multifacility prevention initiative in Orange County, California: A controlled interrupted time series evaluation 2019 ·Infection Control and Hospital Epidemiology ·(unknown),Sarah H. Yi,(unknown),Matt Zahn,Erin Epson	8
10	519. Longer Length of Antibiotic Therapy for Community-Acquired Pneumonia and Risk of Clostridium difficile Infection 2018 ·Open Forum Infectious Diseases ·Sarah H. Yi,Sujan Reddy,Sophia V. Kazakova,Kelly M Hatfield,James Baggs,Alice Guh,Preeta K. Kutty,Lauri A. Hicks,Arjun Srinivasan,L. Clifford McDonald,John A. Jernigan	2
11	Prevalence of probiotic use among inpatients: A descriptive study of 145 U.S. hospitals 2016 ·American Journal of Infection Control ·Sarah H. Yi,John A. Jernigan,L. Clifford McDonald	42
12	Sustained Infection Reduction in Outpatient Hemodialysis Centers Participating in a Collaborative Bloodstream Infection Prevention Effort 2016 ·Infection Control and Hospital Epidemiology ·Sarah H. Yi,Alexander J. Kallen,(unknown),(unknown),(unknown),(unknown),Karen Kelley,(unknown),(unknown),Alicia Shugart,(unknown),(unknown),John A. Jernigan,David G. Kleinbaum,Priti R. Patel	22
13	Protein substitute for children and adults with phenylketonuria 2015 ·Cochrane Database of Systematic Reviews ·Sarah H. Yi,Rani H. Singh	17
14	Medicare Reimbursement Attributable to Periprosthetic Joint Infection Following Primary Hip and Knee Arthroplasty 2015 ·The Journal of Arthroplasty ·Sarah H. Yi,James Baggs,Steven D. Culler,Sandra I. Berríos-Torres,John A. Jernigan	21
15	Activity of Commonly Used Antimicrobial Prophylaxis Regimens against Pathogens Causing Coronary Artery Bypass Graft and Arthroplasty Surgical Site Infections in the United States, 2006–2009 2014 ·Infection Control and Hospital Epidemiology ·Sandra I. Berríos-Torres,Sarah H. Yi,Dale W. Bratzler,Allen Ma,Yi Mu,Li Zhu,John A. Jernigan	50
16	Medicare Reimbursement Attributable to Catheter-associated Urinary Tract Infection in the Inpatient Setting 2014 ·Medical Care ·Sarah H. Yi,James Baggs,Carolyn V. Gould,R. Douglas Scott,John A. Jernigan	21
17	Bloodstream Infection Rates in Outpatient Hemodialysis Facilities Participating in a Collaborative Prevention Effort: A Quality Improvement Report 2013 ·American Journal of Kidney Diseases ·Priti R. Patel,Sarah H. Yi,(unknown),(unknown),(unknown),(unknown),Karen Kelley,(unknown),(unknown),Curt Lindberg,John A. Jernigan,Alexander J. Kallen	83
18	Accuracy of Six Anthropometric Skinfold Formulas Versus Air Displacement Plethysmography for Estimating Percent Body Fat in Female Adolescents with Phenylketonuria 2012 ·JIMD Reports ·Teresa D. Douglas,(unknown),(unknown),Sarah H. Yi,Rani H. Singh	9
19	A randomized, placebo-controlled, double-blind trial of supplemental docosahexaenoic acid on cognitive processing speed and executive function in females of reproductive age with phenylketonuria: A pilot study 2011 ·Prostaglandins Leukotrienes and Essential Fatty Acids ·Sarah H. Yi,Julie A. Kable,Marian L. Evatt,Rani H. Singh	7
20	Factors Influencing Lunchtime Food Choices Among Working Americans 2007 ·Health Education & Behavior ·Heidi M. Blanck,Amy L. Yaroch,Audie A. Atienza,Sarah H. Yi,Jian Zhang,Louise C. Mâsse	61

About Sarah H. Yi

Sarah H. Yi is a scholar working on Applied Microbiology and Biotechnology, Critical Care and Intensive Care Medicine and Emergency Medical Services, having authored 36 papers that have together received 638 indexed citations. Recurring topics across this work include Clostridium difficile and Clostridium perfringens research (8 papers), Antibiotic Use and Resistance (7 papers) and Nosocomial Infections in ICU (7 papers). The work is most often cited by research in Applied Microbiology and Biotechnology (66 citations), Critical Care and Intensive Care Medicine (87 citations) and Emergency Medical Services (87 citations). Sarah H. Yi has collaborated with scholars based in United States, Uganda and Australia. Frequent co-authors include John A. Jernigan, James Baggs, L. Clifford McDonald, Kelly M Hatfield, Rani H. Singh, Sujan Reddy, Sophia V. Kazakova, Sandra I. Berríos-Torres, Louise C. Mâsse and Amy L. Yaroch. Their work appears in journals such as SHILAP Revista de lepidopterología, Clinical Infectious Diseases and The FASEB Journal.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact